TipHub

₹2,424

▲ +24 +1.00%

As of 13 Nov 2026 · delayed

NSE Listed · Pharmaceuticals

Laurus Labs Limited (LAURUSLABS)

Volume: 22,78,466Avg Vol 1W: 27,30,015Avg Vol 1M: 24,60,48852W Range:₹917.95₹2,488
NSE BSE www.lauruslabs.com AI Report
Key Ratios
Checked just now
Market Cap₹1,30,972 Cr
Current Price₹2,424
Previous Close₹2,400
High / Low (52w)₹2,488 / ₹917.95
Volume22,78,466
Avg Vol (1W)27,30,015
Avg Vol (1M)24,60,488
Stock P/E97.74
Book Value₹112.17
Dividend Yield8%
ROE22.11%
ROA11.58%
Revenue (TTM)—
Revenue Growth22.67%
Profit Margin17.13%
Total Debt₹611 Cr
Shares Outstanding54 Cr
Face Value₹2
EPS (TTM)₹24.8
P/B21.61
Debt / Equity0.54
50 DMA₹2,074.3
200 DMA₹1,510.53
Day change+1.00%
Price Chart
₹2,424▲ 142.64% · 1Y
₹2454₹7343.1Cr
2025-11-14
2026-11-13

20-day avg volume: 25.8L shares

Pros
  • Healthy return on equity of 22.1%.
  • Pays a dividend yield of 8.0%.
  • Company is almost debt-free.
  • Revenue grew 15% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 98.
Quarterly Results
MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Revenue₹1,415 Cr₹1,720 Cr₹1,570 Cr₹1,653 Cr₹1,778 Cr₹1,812 Cr₹2,026 Cr₹2,206 Cr
EBITDA₹188 Cr₹369 Cr₹276 Cr₹310 Cr₹365 Cr₹402 Cr₹524 Cr₹636 Cr
Net Profit₹92 Cr₹234 Cr₹163 Cr₹195 Cr₹252 Cr₹279 Cr₹368 Cr₹441 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026Sept 2026
Revenue₹1,650 Cr₹1,433 Cr₹1,567 Cr₹1,509 Cr₹1,580 Cr₹6,868 Cr₹1,757 Cr₹2,014 Cr
EBITDA₹379 Cr₹255 Cr₹323 Cr₹266 Cr₹293 Cr₹1,353 Cr₹423 Cr₹558 Cr
Net Profit₹252 Cr₹158 Cr₹216 Cr₹175 Cr₹192 Cr₹889 Cr₹290 Cr₹388 Cr
EPS—————16.45——
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹3,331 Cr₹3,750 Cr₹5,751 Cr₹6,968 Cr₹7,660 Cr₹8,387 Cr₹9,336 Cr₹10,511 Cr
Total Liabilities₹1,773 Cr₹1,981 Cr₹3,150 Cr₹3,609 Cr₹3,612 Cr₹4,271 Cr₹4,733 Cr₹5,080 Cr
Equity₹1,558 Cr₹1,770 Cr₹2,601 Cr₹3,359 Cr₹4,049 Cr₹4,116 Cr₹4,603 Cr₹5,431 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹323 Cr₹387 Cr₹962 Cr₹1,093 Cr₹1,279 Cr₹770 Cr₹739 Cr₹1,917 Cr
Investing₹-253 Cr₹-221 Cr₹-941 Cr₹-914 Cr₹-996 Cr₹-822 Cr₹-682 Cr₹-1,089 Cr
Financing₹-45 Cr₹-128 Cr₹255 Cr₹30 Cr₹-27 Cr₹250 Cr₹39 Cr₹-525 Cr
Free Cash Flow₹323 Cr₹387 Cr₹962 Cr₹1,093 Cr₹1,279 Cr₹770 Cr₹739 Cr₹1,917 Cr
Shareholding
Promoter 27.47% Institutions 42.7% Public 29.83%
Efficiency & Working Capital
ROCE20.9%
Interest Coverage7.9
Dividend Payout—
Debtor Days115 d
Inventory Days125 d
Payable Days67 d
Cash Conversion Cycle174 d
Working Capital Days241 d
Shareholding Details

As of 2026-09-30

Promoter27.5%
FII30.8%
DII11.9%
Institutions42.7%
Public29.8%
Promoter Pledge2.2%
No. of Shareholders3,11,892
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters27.2%27.2%27.2%27.2%27.6%27.6%27.6%27.6%27.5%27.5%27.5%27.5%
FIIs25.4%26%25.7%26.1%25.6%25.5%25.7%26.2%26.5%25.8%28%30.8%
DIIs10.8%11.8%13.6%13%12.7%11.8%11.9%11.7%12.4%14%13.7%11.9%
Public36.7%35.1%33.6%33.7%34.1%35.1%34.8%34.5%33.6%32.7%30.8%29.8%
Promoter Pledge0%0%0%0%2.7%2.7%2.7%2.7%2.7%2.7%2.7%2.2%
No. of Shareholders3,82,8803,56,8303,24,0593,09,0632,92,2142,92,9052,80,2232,83,6782,80,7562,92,2812,91,6533,11,892
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
M/s. Nsn Holdings (represented By Its Managing Partner, Dr. Satyanarayana Chava)Shareholding of Promoter and Promoter Group23%12.41 Cr
Mirae Asset Nifty India Manufacturing EtfPublic Shareholding4%2.17 Cr
New World Fund IncPublic Shareholding3.5%1.91 Cr
Anukar Projects Private LimitedPublic Shareholding3.2%1.75 Cr
Chunduru Venkata Lakshmana RaoShareholding of Promoter and Promoter Group2.7%1.43 Cr
Smallcap World Fund, IncPublic Shareholding2.3%1.22 Cr
Barclays Wealth Trustees India Private LimitedPublic Shareholding1.6%83,56,485
Akash BhanshaliPublic Shareholding1.3%71,51,700
M/s. Leven Holdings (represented By Its Managing Partner, Mr. Venkata Ravi Kumar Vantaram)Shareholding of Promoter and Promoter Group1.2%62,05,000
Sbi Life Insurance Co. LtdPublic Shareholding1.1%57,90,000
Vanguard Total International Stock Index FundPublic Shareholding1%54,27,616
Satyanarayana ChavaShareholding of Promoter and Promoter Group0.3%15,70,000
Venkata Ravi Kumar VantaramShareholding of Promoter and Promoter Group0.2%10,00,000
Hymavathi VantaramShareholding of Promoter and Promoter Group0%2,25,000
Krishnaveni VasireddiShareholding of Promoter and Promoter Group0%1,90,000
Rama SuryadevaraShareholding of Promoter and Promoter Group0%1,40,000
Narasimha Rao SuryadevaraShareholding of Promoter and Promoter Group0%1,47,500
Nagamani ThokalaShareholding of Promoter and Promoter Group0%1,00,000
Sekhar Babu ChunduruShareholding of Promoter and Promoter Group0%1,00,000
Chava Narasimha RaoShareholding of Promoter and Promoter Group0%1,19,675
Chandrakanth ChereddiShareholding of Promoter and Promoter Group0%42,000
Satya Tej ChavaShareholding of Promoter and Promoter Group0%40,878
Rishi Tej ChavaShareholding of Promoter and Promoter Group0%41,000
Chava Naga RaniShareholding of Promoter and Promoter Group0%0
Soumya ChavaShareholding of Promoter and Promoter Group0%22,940
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Chunduru Venkata Lakshmana Rao32,50,00022.7%2026-09-30
Board of Directors
NameDesignationYear
Ravindranath KancherlaChairman & Independent Directo2026
CHAVA SATYANARAYANAExecutive Director & CEO2026
VENKATA RAVI KUMAR VANTARAMExecutive Director & CFO2026
Venkata Lakshmana Rao ChunduruExecutive Director2026
KRISHNA CHAITANYA CHAVAExecutive Director2026
Soumya ChavaExecutive Director2026
Rajesh Koshy ChandyIndependent Non Exe. Director2026
Karnam SekarIndependent Non Exe. Director2026
Ramesh SubrahmanianIndependent Non Exe. Director2026
Sutapa BanerjeeIndependent Director2026
Shekhar Chintamani MandeIndependent Director2026
Kundan Kumar JhaCompany Secretary / Compliance Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹1,148 Cr99%
Infosystems₹12 Cr1%
Segments — Geography
RegionRevenueShare
Outside India₹1,016 Cr49.1%
Within India₹1,053 Cr50.9%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2111108108
Corporate Actions
TypeDateValueRemark
forthcoming2026-11-06Dividend—
dividend2026-11-06₹1 (50%)Interim
forthcoming2026-07-24Board Meetings—
dividend2026-05-08₹1.2 (60%)Interim 2
dividend2025-10-31₹0.8 (40%)Interim 1
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20261,4491649123331,672
202645494900512
202689470123301,056
Insider / Designated-Person Trades

20 recent disclosure(s)

PRATHIMA CHAVAPledge · 2,00,000
Mrs. G. SreelakshmiDisposal · 10,000
Venkata Jayasree Kumari TadikondaAcquisition · 788
Venkata Jayasree Kumari TadikondaAcquisition · 3,992
Venkata Jayasree Kumari TadikondaAcquisition · 2,906
MADHURI MEDASANIAcquisition · 10,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market18/02/2026 · 1,11,064
Company Information
Incorporated2005
ChairmanRavindranath Kancherla
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]; [email protected]
🌐 www.lauruslabs.com ↗

📍 Plot No 21 Jawaharlal Nehru, Pharma City Parawada, Visakhapatnam, Andhra Pradesh, 531021

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Landsmill Green LimitedLa Opala RGLasa Supergenerics Ltd.Laser Power & Infra Ltd.Latent View AnalyticsLatteys Industries Ltd.Laxmi Cotspin LimitedLaxmi Dental LimitedLaxmi India Finance Ltd.LCC Infotech Ltd.LCC Projects LimitedLohia Corp LimitedAll “L” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search